SCHEMBL6606368

SCHEMBL6606368

Cc1cc2cc(N)ccc2n1-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.58
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
KDM4E B2RXH2 5/20 0.44
MAPT P10636 4/20 0.44
CASP1 P29466 3/20 0.44
CASP7 P55210 3/20 0.44
ALOX15 P16050 3/20 0.44
BRPF1 P55201 2/20 0.42
HSD17B10 Q99714 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MAPK1 P28482 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 2/20 0.41
FGFR1 P11362 1/20 0.41
PRKCI P41743 1/20 0.41
NOTUM Q6P988 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11723689 0.82 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL1664109 0.82 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL6986420 0.81 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL16720746 0.80 USP14 (0.44) ALDH1A1KDM4EMAPTBRPF1MAPK1
SCHEMBL30446730 0.80 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL1885602 0.80 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL11988035 0.79 AVPR1A (0.45) ALDH1A1MEN1KMT2AKDM4ECASP1
SCHEMBL3128695 0.79 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL4405521 0.76 HSD17B10 (0.61) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL17505192 0.75 BRPF1 (0.56) ALDH1A1MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed